FDA Inspection
Kentucky Blood Center IncKentucky Blood Center Inc – FDA Inspection, Jul 12, 2013
Record Details
This FDA Inspection record concerns Kentucky Blood Center Inc, with an inspection on July 12, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Kentucky Blood Center Inc
- Inspection Date
- July 12, 2013
- Product Type
- Biologics
View Company Profile
ID · 72c20fdb-1baf-4e3b-b3a4-55e5f78e87e8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 840133
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 803.17Lack of Written MDR Procedures
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kentucky Blood Center Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2025 | VAI | Cincinnati District Office | Blood and Blood Products |
| September 18, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Kentucky Blood Center Inc
- FDA Inspection 1282752 - 2025-09-22
- FDA Inspection 1218308 - 2023-09-18
- FDA Inspection 1100136 - 2019-08-16
- FDA Inspection 1021264 - 2017-07-28
- FDA Inspection 941492 - 2015-09-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.